What metric defines Ormat Technologies ORA success this quarter Q1 2026 EPS Tops Views AGEN Agenus posts far narrower Q4 2025 loss than analyst estimates shares rise 469 percent today MCY Mercury surges 61 above estimates on Q1 EPS beat but stock gains only 2 as investors seek caution Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue What would it take for Canterbury CPHC to double from here Buying Pressure 20260508 The opportunity most miss about Cre8 CRE Technical Strength 20260505 What strategy margin NAPCO NSSC Buying Pressure 20260501 BIPI BIP Perp latest quarterly filings offer no explicit earnings or operational performance details for investors 30Year US Treasury Yield Reaches Highest Level Since 2007 Amid Persistent Inflation Concerns Enerpac EPAC Rallies 151 as Bulls Target 3531 20260520 MGE Energy MGEE Q1 2026 Earnings EPS 132 Beats Estimates Neurogene NGNE Q1 2026 Results Miss Estimates EPS 139 vs 132